Related Experiment Video

Updated: Jun 23, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

Molecular pathogenesis of cutaneous melanocytic neoplasms

Nageatte Ibrahim1, Frank G Haluska

  • 1Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA. nibrahim@partners.org

Annual Review of Pathology
|April 30, 2009
PubMed

Insights

Understanding melanoma genetics reveals key genes like CDKN2A and BRAF, offering new therapeutic targets for this deadly skin cancer. Research highlights genes in cell cycle, apoptosis, and tumor suppression for effective treatment strategies.

Area of Science:

  • Oncology
  • Genetics
  • Dermatology

Background:

  • Melanoma is a severe skin cancer lacking effective treatments.
  • Advances in understanding its genetic basis are crucial for developing therapies.
  • Familial and sporadic melanoma share common genetic underpinnings.

Purpose of the Study:

  • To review major genes implicated in melanoma development.
  • To highlight key genes including CDKN2A, CDK4, MC1R, and MAPK pathway targets.
  • To discuss novel therapeutic avenues based on genetic insights.

Main Methods:

  • Literature review of genetic factors in melanoma.
  • Focus on genes regulating cell cycle, apoptosis, and tumor suppression.
  • Analysis of familial and sporadic melanoma genetic data.

Main Results:

  • Identified key genes: CDKN2A, CDK4, MC1R, RAS, BRAF, BCL-2, AKT, APAF-1, TP53, PTEN.
  • Elucidated the role of these genes in melanomagenesis.
  • Established a link between genetic mutations and melanoma progression.

Conclusions:

  • Genetic understanding is advancing melanoma treatment.
  • Targeting specific genes offers new therapeutic strategies.
  • Further research into melanoma genetics will improve patient outcomes.

More Related Videos

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

A 3D Organotypic Melanoma Spheroid Skin Model08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Related Concept Videos

Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...